Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms

Clinical trial NCT00801944 · COMPLETED

Trial details

NCT number: NCT00801944
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2004-04-01
Primary completion: 2005-10-01
Enrollment: 973

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.